your market intelligence analyst
Search Results
Edit Save
135 results
Cardiovascular News 09/20/2019 06:23
Ashok Seth (New Delhi, India) talks to BLearning at EuroPCR 2019 (21–24 May, Paris, France) about the MyVal-1 study which looked at the one-year clinical outcomes of India’s first indigenously designed and manufactured TAVR system. This was the first in-human study of the device which was performed as per the regulatory authorities of India. Seth outlines the key findings from […]. .
Cardiovascular News 09/20/2019 06:06
Boston Scientific has announced the key data that will be presented at the Transcatheter Cardiovascular Therapeutics conference (TCT 2019; 25–29 September, San Francisco, USA). Data from the EVOLVE Short DAPT study, evaluating the safety of early dual antiplatelet therapy discontinuation in a large number of patients with high bleeding risk treated with the SYNERGY™ bioabsorbable […]. .
Cardiovascular News 09/20/2019 04:57
Corindus Is to showcase the CorPath GRX system at the Transcatheter Cardiovascular Therapeutics Conference (TCT 2019; 25–29 September, San Francisco, USA). CorPath GRX is the only US Food and Drug Administration (FDA) cleared and CE-marked medical device for robotic-assisted vascular interventions. The company says that attendees will be able to gain hands-on experience with CorPath […]. .
Cardiovascular News 09/19/2019 06:00
Abbott has announced its TRILUMINATE Pivotal trial to evaluate the safety and effectiveness of the TriClip transcatheter tricuspid valve repair system for the treatment of severe tricuspid regurgitation. This is the first pivotal Investigational Device Exemption (IDE) trial in the USA to evaluate a catheter-based, non-surgical treatment for patients with severe tricuspid regurgitation. The first […]. .
Cardiovascular News 09/16/2019 11:42
AtriCure has entered into a definitive agreement to acquire SentreHEART, which developed the LARIAT device for left atrial appendage closure in patients with atrial fibrillation. A press release reports that the transaction consideration consists of an upfront payment of approximately US$40 million in cash and AtriCure common stock, plus additional contingent consideration based on the […]. .
Cardiovascular News 09/10/2019 07:07
Caution: This content is only for readers outside of France, Japan and the US. In the US, ACURATE neo is limited by U.S. law to investigational use only. Not available for sale. Since the first implant 17 years ago, transcatheter aortic valve implantation (TAVI) has become a routine procedure for inoperable and high-risk patients. Furthermore, […]. .
Cardiovascular News 09/06/2019 14:35
A new study indicates that the Meridian transcatheter aortic valve implantation (TAVI) valve (HLT) is associated with a 30-day mortality rate of 8% and a six-month mortality rate of 12%. The valve is fully retrievable after deployment, which allows an accurate assessment of valve positioning and performance prior to final release. Most self-expanding devices are […]. .
Cardiovascular News 09/05/2019 11:27
Merit Medical Systems, a leading manufacturer and marketer of proprietary devices used primarily in cardiology, radiology, oncology, and endoscopy, has announced the commercial launch of the PreludeSYNC EVO radial compression device in the USA. PreludeSYNC EVO is a sterile, single-use, disposable device used to assist in gaining hemostasis of the arterial percutaneous access site following […]. .
Cardiovascular News 09/03/2019 06:43
Yesterday, Jean-Francois Obadia (Hopital Cardiovasculaire Louis Pradel, Chirurgie Cardio-Vasculaire et Transplantation Cardiaque, Lyon, France) reported that the two-year results of MITRA-FR indicate that percutaneous edge-to-edge repair in patients with secondary mitral regurgitation do not significantly reduce the composite rate of all-cause death and hospitalisation for heart failure compared with medical therapy.
Cardiovascular News 09/02/2019 13:27
One-year data from the BIOSTEMI study, simultaneously published in the Lancet and presented today at the ESC, indicates that patients with ST-segment elevation myocardial infarction (STEMI) who undergo percutaneous coronary intervention (PCI) with an ultrathin, sirolimus-eluting stent with a biodegradable polymer (Orsiro, Biotronik) have a significantly lower rate of target lesion failure than those who [...]. .
Cardiovascular News 09/01/2019 14:07
A strategy of complete revascularisation was superior to culprit lesion-only percutaneous coronary intervention (PCI) in reducing the risk of cardiovascular death or myocardial infarction (MI) in patients with ST-segment myocardial infarction (STEMI) and multivessel coronary artery disease, as well as reducing the risk of a composite of CV death, MI or ischaemia driven revascularisation.
Cardiovascular News 09/01/2019 03:22
At the 2019 European Society Cardiology (ESC) congress (31 August – 4 September, Paris, France), Abiomed revealed that its Impella CP with SmartAssist technology is now commercially available in Europe. A press release reports that the system is designed to improve patient outcomes with advanced algorithms and simplified patient management. It adds that the majority of […]. .
Cardiovascular News 08/23/2019 08:57
A polypill that combines four cardiovascular drugs has been shown to reduce the risk of major cardiovascular events in the general population when taken in a low-dose once-daily. Findings from the PolyIran study, a five-year randomised controlled trial, were published in The Lancet, and are the first to demonstrate a role for such treatment in […]. .
Cardiovascular News 08/23/2019 06:18
CeloNova has announced the appointment of Carl J St. Bernard as president and chief executive officer (CEO). According to CeloNova, St. Bernard joins the company from Tryton Medical where he was President and CEO, leading the company’s commercialisation efforts in the coronary stent market. St. Bernard’s previous experience includes vice president at Johnson & Johnson […]. .

Chemicals - Agricultural

Chemicals - Industrial

Business Issues

Companies - Public

Companies - Venture Funded

Commodity Prices

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Information Technologies

Legal and Regulatory

Political Entities


Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications